Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06571136

The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

Identification of COVID-19 Infection from Measurement of Exhaled Breath

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
N5 Sensors · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured. Changes in the amount and type of chemicals in breath will be used to determine if an individual does or does not have COVID infection. If the measurements of breath are a reliable measure of COVID infection, this device may be used to rapidly screen people who are attending large public events (for example, music concert or baseball game) to minimize the spread of COVID at the event.

Detailed description

N5 Sensors has developed a device that can measure chemical concentrations at parts-per-billion levels (for example, 10 molecules in one-billion molecules is 10 parts-per-billion). This device will be used to measure a variety of chemicals in the exhaled breath of human volunteers. The measured chemicals have been selected based on their presence in the breath of subjects with COVID infection. In addition to measuring breath, samples of mucus from the nose of these same subjects will be collected. These nasal samples will be evaluated to determine the presence of the COVID virus and of COVID infection. Changes in chemicals in the breath will be compared to the presence of COVID or to infection with COVID. This comparison will determine if measurement of breath can be used as a quick and simple measure of COVID infection.

Conditions

Timeline

Start date
2024-08-19
Primary completion
2025-02-01
Completion
2025-02-26
First posted
2024-08-26
Last updated
2024-11-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06571136. Inclusion in this directory is not an endorsement.